| 영문 | influenza | 한글 | 인플루엔자 |
|---|---|---|---|
| 설명 | 기도를 침범하는 바이러스 감염증. 지역유행성, 유행성 또는 범발성으로 발생한다. 범발성의 경우는 여러 대륙을 동시에 또는 연속적으로 침범한다. 코점막, 인두, 결막의 염증, 두통, 때때로 전신의 심한 근육통이 특징이다. 심장근과 중추신경계가 침해되는 일은 적다. 괴사기관지염과 간질폐렴이 중증 인플루엔자의 주된 증상이다. 환자는 폐렴알균(Streptococcus pneumoniae), 인플루엔자균(Hemophilus influenzae), 황색포도알균(Staphylococus aureus)에 의한 속발성 세균성 폐렴에 걸리기 쉽다. 잠복기는 1~3, 질병기간은 통상 3~10일이다. 인플루엔자는 A(많은 아군이 있다), B, C로 이름지어진 여러 가지의 혈청학적으로 다른 바이러스주에 의해 발생한다. |
||
| 영문 | influenza virus | 한글 | 인플루엔자바이러스 |
|---|---|---|---|
| 설명 | 인플루엔자의 병원체. 상기도 점막에 침입하여 호흡기 질환을 일으킨다. 보체 결합 항원의 차이에 따라 A-B-C 세형태로 나뉘며, 유행할 때마다 혈구 응집 항원이 변이하여 광범위한 유행을 나타낸다. 껍질이 있는 80~150nm의 공모양, 나선 대칭 RNA 바이러스이다. 두 종류의 스파이크, 뉴라미니다아제(neuraminidase, NA), 당단백질과 헤마글루티닌(hemagglution, HA) 당단백질을 만든다. A형의 NA에는 N1-N2의 두 종류, HA에는 HAO-HA1-HA2-HA3의 네 종류가 있다. A형은 말-돼지-새에 감염하며 새로운 아형은 동물 바이러스와의 조환형이며, 그 밖에 동일 아형내 점변이가 있다. B, C형은 사람 이외에는 감염되지 않는다. 닭의 적혈구를 응집하는 성질이 있다. 바이러스 진단에는 환자의 인두 세척액에서 분리한다든가, 또는 환자의 혈청항체에 의한 특이적 적혈구 응집저지검사, 뉴라미니다아제 활성저지검사 또는 중화검사 등으로 검출한다. |
||
| TVS | transvesical sonography |
|---|---|
| DT-VAC | diphtheria-tetanus vaccine |
| VAC | ventriculoatrial conduction; vincristine, doxorubicin, and cyclophosphamide; virus capsid antigen |
| vac | vacuum |
| HBPV | Haemophilus influenza type B Polysaccharide(PRP) Vaccine; B형 헤모필루스 인플루엔자 피막 다당질 백신... |
| PEDI | Paediatric Evaluation of Disability Inventory |
|---|---|
| TVS | Trans-Vaginal Sonography |
| TVS | Transvaginal ultrasonography |
| TVS | Transvaginal ultrasound |
| TVS | Tubulovesicular structures |
| VAC | <abbreviation> Ventriculoatrial conduction. (05 Mar 2000) |
|---|---|
| Asian influenza | A worldwide influenza, apparently originating in China in the summer of 1957, which produces a milder disease than that of the pandemic of 1917-1919. (05 Mar 2000) |
| avian influenza | Infection of domestic and wild fowl and other birds with influenza a virus, avian. (12 Dec 1998) |
| avian influenza virus | <virology> A type A influenza virus (genus Influenzavirus) that causes fowl plague. Synonym: fowl plague virus. (05 Mar 2000) |
| vaccine, influenza | See Vaccine, flu. Vaccination, dtap: like dpt, dtap protects from diphtheria, pertussis (whooping cough) and tetanus. Dtap is the same as dtp, except that it contains only acellular pertussis vaccine which is thought to cause fewer of the minor reactions associated with immunization and is also probably less likely to cause the more severe reactions occasionally seen following pertussis vaccination. Dtap is currently recommended only for the shots given at 18 months and 4-6 years of age. Vaccination, dt: dt (diphtheria and tetanus) vaccine does not protect from pertussis and is usually reserved for individuals who have had a significant adverse reaction to a dpt shot or who have a personal or family history of a seizure disorder or brain disease. (12 Dec 1998) |
| Russian influenza | A pandemic of a strain influenza A virus thought to have originated in Russia; occurred in 1978. (05 Mar 2000) |
| haemagglutinin glycoproteins, influenza virus | Membrane glycoproteins from influenza viruses which are involved in haemagglutination, virus attachment, and envelope fusion. Fourteen distinct subtypes of ha glycoproteins and nine of na glycoproteins have been identified from influenza a virus; no subtypes have been identified for influenza b or influenza c viruses. (12 Dec 1998) |
| Haemophilus influenza | <bacteria> A gram-negative bacteria that is a common cause for epiglottitis, meningitis, conjunctivitis, sepsis and respiratory infections. Haemophilus influenza type b is a gram-negative bacteria that is responsible for a significant percentage of bacterial sepsis (blood-borne infection) cases in infants under 4 months of age (pneumonia, epiglottitis, sepsis, septic arthritis, cellulitis). There is a new vaccination available to protect against this common infant pathogen (HIB vaccine, haemophilus influenza b vaccine). (27 Sep 1997) |
| Haemophilus influenza b vaccine | <virology> A vaccination that is given to infants to protect against infection with haemophilus influenza b, an important cause of neonatal sepsis. Typically administered at 2, 4, 6 and 15 months. Children who are aged 15 months to 5 years, who have not received the vaccine, should be given a single injection of haemophilus b conjugate vaccine. Acronym: HIB (26 Mar 1998) |
| Haemophilus influenza meningitis | <disease> A form of meningitis caused by the bacterium haemophilus influenza. Inflammation of the membranes (meninges) covering the brain and spinal cord can result after infection with this organism. Influenza meningitis occurs most frequently in children under 5 years old. Onset may be sudden or occur more slowly after an upper respiratory infection. Symptoms and features include fever, headache, stiff neck, photophobia and mental status changes. Infants may be irritable and exhibit poor feeding associated with fever. Severe cases may progress to seizures, coma and death. Treatment always includes high-dose systemic antibiotics and corticosteroids may also be used in some select cases. (27 Sep 1997) |
| Hong Kong influenza | Influenza caused by a serotype of influenza virus type A and first identified in Hong Kong. (05 Mar 2000) |
| Spanish influenza | Influenza that caused several waves of pandemic in 1918-1919, resulting in more than 20 million deaths worldwide; it was particularly severe in Spain (hence the name), but now is thought to have originated in the U.S. As a form of swine influenza. (05 Mar 2000) |
| swine influenza | An acute respiratory disease of swine caused by strains of influenza virus type A; it is believed to have become adapted to swine in the United States during the great human pandemic in 1918; fatal cases, as in such cases of pandemic influenza in man, are commonly associated with secondary bacterial pneumonia. (05 Mar 2000) |
| swine influenza viruses | Strains of influenza virus type A which cause influenza of swine and can infect humans. (05 Mar 2000) |
| duck influenza virus | An influenza A virus, a member of the family Orthomyxoviridae, distinct from human influenza A strains on bases of haemagglutination-inhibition. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|